Cargando…
FSHR Trans-Activation and Oligomerization
Follicle stimulating hormone (FSH) plays a key role in human reproduction through, among others, induction of spermatogenesis in men and production of estrogen in women. The function FSH is performed upon binding to its cognate receptor—follicle-stimulating hormone receptor (FSHR) expressed on the s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301190/ https://www.ncbi.nlm.nih.gov/pubmed/30619090 http://dx.doi.org/10.3389/fendo.2018.00760 |
_version_ | 1783381796518363136 |
---|---|
author | Szymańska, Kamila Kałafut, Joanna Przybyszewska, Alicja Paziewska, Beata Adamczuk, Grzegorz Kiełbus, Michał Rivero-Müller, Adolfo |
author_facet | Szymańska, Kamila Kałafut, Joanna Przybyszewska, Alicja Paziewska, Beata Adamczuk, Grzegorz Kiełbus, Michał Rivero-Müller, Adolfo |
author_sort | Szymańska, Kamila |
collection | PubMed |
description | Follicle stimulating hormone (FSH) plays a key role in human reproduction through, among others, induction of spermatogenesis in men and production of estrogen in women. The function FSH is performed upon binding to its cognate receptor—follicle-stimulating hormone receptor (FSHR) expressed on the surface of target cells (granulosa and Sertoli cells). FSHR belongs to the family of G protein-coupled receptors (GPCRs), a family of receptors distinguished by the presence of various signaling pathway activation as well as formation of cross-talking aggregates. Until recently, it was claimed that the FSHR occurred naturally as a monomer, however, the crystal structure as well as experimental evidence have shown that FSHR both self-associates and forms heterodimers with the luteinizing hormone/chorionic gonadotropin receptor—LHCGR. The tremendous gain of knowledge is also visible on the subject of receptor activation. It was once thought that activation occurs only as a result of ligand binding to a particular receptor, however there is mounting evidence of trans-activation as well as biased signaling between GPCRs. Herein, we describe the mechanisms of aforementioned phenomena as well as briefly describe important experiments that contributed to their better understanding. |
format | Online Article Text |
id | pubmed-6301190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63011902019-01-07 FSHR Trans-Activation and Oligomerization Szymańska, Kamila Kałafut, Joanna Przybyszewska, Alicja Paziewska, Beata Adamczuk, Grzegorz Kiełbus, Michał Rivero-Müller, Adolfo Front Endocrinol (Lausanne) Endocrinology Follicle stimulating hormone (FSH) plays a key role in human reproduction through, among others, induction of spermatogenesis in men and production of estrogen in women. The function FSH is performed upon binding to its cognate receptor—follicle-stimulating hormone receptor (FSHR) expressed on the surface of target cells (granulosa and Sertoli cells). FSHR belongs to the family of G protein-coupled receptors (GPCRs), a family of receptors distinguished by the presence of various signaling pathway activation as well as formation of cross-talking aggregates. Until recently, it was claimed that the FSHR occurred naturally as a monomer, however, the crystal structure as well as experimental evidence have shown that FSHR both self-associates and forms heterodimers with the luteinizing hormone/chorionic gonadotropin receptor—LHCGR. The tremendous gain of knowledge is also visible on the subject of receptor activation. It was once thought that activation occurs only as a result of ligand binding to a particular receptor, however there is mounting evidence of trans-activation as well as biased signaling between GPCRs. Herein, we describe the mechanisms of aforementioned phenomena as well as briefly describe important experiments that contributed to their better understanding. Frontiers Media S.A. 2018-12-13 /pmc/articles/PMC6301190/ /pubmed/30619090 http://dx.doi.org/10.3389/fendo.2018.00760 Text en Copyright © 2018 Szymańska, Kałafut, Przybyszewska, Paziewska, Adamczuk, Kiełbus and Rivero-Müller. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Szymańska, Kamila Kałafut, Joanna Przybyszewska, Alicja Paziewska, Beata Adamczuk, Grzegorz Kiełbus, Michał Rivero-Müller, Adolfo FSHR Trans-Activation and Oligomerization |
title | FSHR Trans-Activation and Oligomerization |
title_full | FSHR Trans-Activation and Oligomerization |
title_fullStr | FSHR Trans-Activation and Oligomerization |
title_full_unstemmed | FSHR Trans-Activation and Oligomerization |
title_short | FSHR Trans-Activation and Oligomerization |
title_sort | fshr trans-activation and oligomerization |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301190/ https://www.ncbi.nlm.nih.gov/pubmed/30619090 http://dx.doi.org/10.3389/fendo.2018.00760 |
work_keys_str_mv | AT szymanskakamila fshrtransactivationandoligomerization AT kałafutjoanna fshrtransactivationandoligomerization AT przybyszewskaalicja fshrtransactivationandoligomerization AT paziewskabeata fshrtransactivationandoligomerization AT adamczukgrzegorz fshrtransactivationandoligomerization AT kiełbusmichał fshrtransactivationandoligomerization AT riveromulleradolfo fshrtransactivationandoligomerization |